Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Signa Vitae is Scopus-indexed (Q3, CiteScore 1.2). Published by Pharmamed Mado Ltd.
Checked against the index lists dated .
ISSN 1334-5605Verify ISSN ↗1845-206XVerify ISSN ↗
Publisher: Pharmamed Mado Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Emergency Medicine | 68 / 111 | 39th | Q3 |
| Critical Care and Intensive Care Medicine | 77 / 122 | 37th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q3, CiteScore 1.2.
Signa Vitae is Q3 in Emergency Medicine (rank 68 of 111) and Q3 in Critical Care and Intensive Care Medicine (rank 77 of 122), by CiteScore 2025.
Signa Vitae is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.2, quartile Q3, 39th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.227, quartile Q3, with an H-index of 17.
Signa Vitae is published by Pharmamed Mado Ltd. Its print ISSN is 1334-5605 and its online ISSN is 1845-206X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Signa Vitae has an h-index of 17 and a 2-year mean of 0.63 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #65 of 109 Scopus journals in Emergency Medicine.
Signa Vitae published 201 papers in 2025; its busiest recent year was 2021 with 261. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 44 research articles (2025–2026), authors are most often from Türkiye (23.9%), China (20.5%) and Italy (15.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.